News
Joey Chestnut is set to return to the Nathan’s Hot Dog Eating Contest Friday, July 4 after a one-year ban due to a ...
The new mother had a normal recovery from childbirth. But a month later, she was beset by debilitating symptoms.
A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a ...
Asthma affects more than 300 million people worldwide, and is the most common noncommunicable disease among children. No cure exists for chronic asthma; most patients rely on inhaled or systemic ...
GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...
Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, researchers have found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results